We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Bio-Innovation Agreement to Strengthen Ties between Canada and Israel

By LabMedica International staff writers
Posted on 31 May 2016
A recently signed agreement aims at encouraging academic and entrepreneurial ties in the field of bio-innovation between a Canadian and an Israeli university.

The agreement will establish a strong relationship between the University of Toronto (Canada) – in the form of the Institute of Biomaterials and Biomedical Engineering – and The Hebrew University of Jerusalem (Israel) – in the form of the Alexander Grass Center for Bioengineering.

The agreement, which is called the Jerusalem-Toronto Bio-Innovation Partnership, will strengthen the exchange of students, faculty, and ideas between the academic and entrepreneurial environments of the two universities. More...
In addition, it will provide financial support for students in engineering, biology, and computer science to conduct research in the partner country over a 12-week period.

An intensive eight-week educational program – the Transdisciplinary Innovation Program – that weaves together computer vision, big data, and bioengineering will also be offered to students from the University of Toronto, enabling interaction with Nobel laureates, work under the mentorship of Israeli scientists and entrepreneurs, and the opportunity for students to pitch ideas to investors.

Faculty and student groups will travel between the two countries to advance the collaboration, and a joint BioDesign program will bring together engineers, clinicians, and business and engineering students to share and create knowledge with tangible impact.

Dr. Meric Gertler, president of the University of Toronto, said, “The forthcoming projects with The Hebrew University of Jerusalem are important to the University of Toronto. They underscore a commitment on the part of both universities to harness the power of Israel’s and Canada’s brightest minds to find solutions to the world's pressing social and medical problems. They will provide exciting opportunities in the near-term and, I believe, stand to have meaningful long-run impact by virtue of the skills investment and advances they entail.”

Dr. Menahem Ben-Sasson, president of The Hebrew University of Jerusalem, said, “The Hebrew University is very pleased to expand its partnership with the University of Toronto. This agreement will bring about new exchanges of people and ideas between two of the world’s leading centers of research and academia. Furthermore it will drive cooperation in medical, social and entrepreneurial studies and research that will benefit Canada, Israel and the entire world.”

Related Links:
University of Toronto
The Hebrew University of Jerusalem


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: AI-powered ctDNA analysis provides clinicians with a new lens to monitor disease evolution (Photo courtesy of Brandon Stelter, Katie Han, Kyle Smith, and Paul Northcott)

AI-Powered Liquid Biopsy Classifies Pediatric Brain Tumors with High Accuracy

Liquid biopsies offer a noninvasive way to study cancer by analyzing circulating tumor DNA in body fluids. However, in pediatric brain tumors, the small amount of ctDNA in cerebrospinal fluid has limited... Read more

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Pathology

view channel
Image: Sophie Paczesny, M.D., Ph.D and her team have made BIOPREVENT freely available for researchers and clinician to test and learn from (Photo courtesy of Cliff Rhodes)

AI Tool Uses Blood Biomarkers to Predict Transplant Complications Before Symptoms Appear

Stem cell and bone marrow transplants can be lifesaving, but serious complications may arise months after patients leave the hospital. One of the most dangerous is chronic graft-versus-host disease, in... Read more

Industry

view channel
Image: QuidelOrtho has entered into a strategic supply agreement with Lifotronic to expand its global immunoassay portfolio (Photo courtesy of QuidelOrtho)

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.